| |
| |
|
| Insider
Information: |
Frates James M |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
318,827 |
|
|
Indirect Shares
|
184,010 |
|
|
| Direct
Value |
$2,217,646 |
|
|
|
Indirect Value
|
$3,759,406 |
|
|
| Total
Shares |
502,837 |
|
|
| Total
Value |
$5,977,053 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alkermes Plc |
ALKS |
SVP, Alks Inc; CFO ALKS |
2020-05-14 |
91,828 |
2020-05-14 |
155,669 |
Premium* |
|
|
Sage Therapeutics, Inc. |
SAGE |
|
2021-06-16 |
1,035 |
2021-06-16 |
1,810 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-04-16 |
225,964 |
2024-04-16 |
26,531 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
262 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-05-16 |
4 |
AS |
$26.93 |
$875,451 |
D/D |
(32,500) |
55,676 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2016-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
56,537 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2016-05-28 |
4 |
D |
$46.13 |
$54,295 |
D/D |
(1,177) |
56,601 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2016-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
57,778 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2019-09-13 |
4 |
OE |
$11.74 |
$234,800 |
D/D |
20,000 |
58,256 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-06-16 |
4 |
OE |
$11.74 |
$117,400 |
D/D |
10,000 |
58,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-08-11 |
4 |
OE |
$14.38 |
$143,800 |
D/D |
10,000 |
58,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-08-13 |
4 |
OE |
$8.55 |
$172,700 |
D/D |
15,000 |
59,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-11-10 |
4 |
OE |
$15.95 |
$159,500 |
D/D |
10,000 |
59,857 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-08-27 |
4 |
OE |
$8.55 |
$187,600 |
D/D |
16,000 |
60,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-09-10 |
4 |
OE |
$8.55 |
$187,600 |
D/D |
16,000 |
60,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-09-24 |
4 |
OE |
$8.55 |
$187,600 |
D/D |
16,000 |
60,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-10-08 |
4 |
OE |
$8.55 |
$187,600 |
D/D |
16,000 |
60,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2020-02-16 |
4 |
D |
$17.77 |
$20,826 |
D/D |
(1,172) |
60,459 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2020-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,375 |
61,631 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2016-08-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,437 |
61,924 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2020-02-17 |
4 |
D |
$17.77 |
$16,064 |
D/D |
(904) |
62,555 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2020-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
63,459 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-03-16 |
4/A |
OE |
$6.88 |
$223,600 |
D/D |
32,500 |
66,509 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2020-02-21 |
4 |
D |
$20.24 |
$34,651 |
D/D |
(1,712) |
66,668 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2020-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,825 |
68,380 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-07-14 |
4 |
OE |
$11.74 |
$261,200 |
D/D |
20,000 |
68,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-09-15 |
4 |
OE |
$11.74 |
$261,200 |
D/D |
20,000 |
68,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2020-03-01 |
4 |
D |
$20.84 |
$27,571 |
D/D |
(1,323) |
69,845 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2020-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
71,168 |
0 |
- |
|
262 Records found
|
|
Page 4 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
